BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10999746)

  • 41. Estrogen receptor alpha/beta, AIB1, and TIF2 in colorectal carcinogenesis: do coregulators have prognostic significance?
    Grivas PD; Tzelepi V; Sotiropoulou-Bonikou G; Kefalopoulou Z; Papavassiliou AG; Kalofonos H
    Int J Colorectal Dis; 2009 Jun; 24(6):613-22. PubMed ID: 19198856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estrogen and progesterone receptors in meningiomas.
    Maiuri F; Montagnani S; Gallicchio B
    Surg Neurol; 1986 Nov; 26(5):435-40. PubMed ID: 3764648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An audit of immunohistochemical marker patterns in meningioma.
    Baxter DS; Orrego A; Rosenfeld JV; Mathiesen T
    J Clin Neurosci; 2014 Mar; 21(3):421-6. PubMed ID: 24231566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The biology of meningiomas.
    Smith DA; Cahill DW
    Neurosurg Clin N Am; 1994 Apr; 5(2):201-15. PubMed ID: 8032223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis.
    Kefalopoulou Z; Tzelepi V; Zolota V; Grivas PD; Christopoulos C; Kalofonos H; Maraziotis T; Sotiropoulou-Bonikou G
    J Neurooncol; 2012 Jan; 106(1):23-31. PubMed ID: 21735116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New Insights into Expression of Hormonal Receptors by Meningiomas.
    Portet S; Banor T; Bousquet J; Simonneau A; Flores M; Ingrand P; Milin S; Karayan-Tapon L; Bataille B
    World Neurosurg; 2020 Aug; 140():e87-e96. PubMed ID: 32371078
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic ablation of the steroid receptor coactivator-ubiquitin ligase, E6-AP, results in tissue-selective steroid hormone resistance and defects in reproduction.
    Smith CL; DeVera DG; Lamb DJ; Nawaz Z; Jiang YH; Beaudet AL; O'Malley BW
    Mol Cell Biol; 2002 Jan; 22(2):525-35. PubMed ID: 11756548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Steroid receptors in brain tumors].
    Robustelli della Cuna G; Zibera C; Fortunati D; Pavesi L; Preti P; Knerich R; Adinolfi D
    Minerva Med; 1984 May; 75(21):1287-92. PubMed ID: 6728275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of steroid receptor coactivator-3 in bone cancers: an in vivo immunohistochemical study with tissue microarray.
    Luo F; Li W; Zhang J; Huang K; Fu J; Xie Z
    Pathol Res Pract; 2013 Dec; 209(12):790-6. PubMed ID: 24134957
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Steroid receptor proteins in human meningiomas.
    Tilzer LL; Plapp FV; Evans JP; Stone D; Alward K
    Cancer; 1982 Feb; 49(4):633-6. PubMed ID: 7055777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for involvement of steroid receptors and coactivators in neuroepithelial and meningothelial tumors.
    Liu M; Zhang K; Zhao Y; Guo Q; Guo D; Zhang J
    Tumour Biol; 2015 May; 36(5):3251-61. PubMed ID: 25534237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estrogen- and progesterone-receptors in meningiomas. Review article.
    Goffin J
    Clin Neurol Neurosurg; 1986; 88(3):169-75. PubMed ID: 3536253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of estrogen receptors, androgen receptor and steroid receptor coactivator-3 is negatively correlated to the differentiation of astrocytic tumors.
    Liu C; Zhang Y; Zhang K; Bian C; Zhao Y; Zhang J
    Cancer Epidemiol; 2014 Jun; 38(3):291-7. PubMed ID: 24680642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SRC-3 has a role in cancer other than as a nuclear receptor coactivator.
    Ma G; Ren Y; Wang K; He J
    Int J Biol Sci; 2011; 7(5):664-72. PubMed ID: 21647249
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene.
    Xu J; Qiu Y; DeMayo FJ; Tsai SY; Tsai MJ; O'Malley BW
    Science; 1998 Mar; 279(5358):1922-5. PubMed ID: 9506940
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Steroid hormone binding macromolecules in meningiomas. Failure to meet criteria of specific receptors.
    Schwartz MR; Randolph RL; Cech DA; Rose JE; Panko WB
    Cancer; 1984 Feb; 53(4):922-7. PubMed ID: 6198062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hyperstosis in patients with intracranial meningioma--secondary changes in tumor invasion].
    Kvasha MS
    Lik Sprava; 2002; (3-4):90-3. PubMed ID: 12145904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Steroid receptors in human brain and spinal cord tumors.
    Kornblum JA; Bay JW; Gupta MK
    Neurosurgery; 1988 Aug; 23(2):185-8. PubMed ID: 3185877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hormone therapies in meningioma-where are we?
    Miyagishima DF; Moliterno J; Claus E; Günel M
    J Neurooncol; 2023 Jan; 161(2):297-308. PubMed ID: 36418843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coactivation of an endogenous progesterone receptor by TIF2 in COS-7 cells.
    Hofman K; Swinnen JV; Verhoeven G; Heyns W
    Biochem Biophys Res Commun; 2002 Jul; 295(2):469-74. PubMed ID: 12150973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.